documents: FDA-2007-D-0369-0053
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | agency_id | docket_id | title | document_type | subtype | posted_date | posted_year | posted_month | comment_start_date | comment_end_date | last_modified | fr_doc_num | open_for_comment | withdrawn | object_id |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| FDA-2007-D-0369-0053 | FDA | FDA-2007-D-0369 | Attachment 3 - "Exelon Patch (Rivastigmine Transdermal System)" - [Novartis Pharmaceuticals Corporation - Comment] re FDA-2007-D-0369-0051 | Supporting & Related Material | C-Comment (Supporting and Related Material) | 2011-01-31T05:00:00Z | 2011 | 1 | 2011-01-31T22:17:40Z | 0 | 0 | 0900006480b82b50 |
Links from other tables
- 0 rows from regs_document_id in fr_regs_crossref